Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc
- This topic has 0 replies, 1 voice, and was last updated 2 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
https://www.thelancet.com/article/S1470-2045(20)30321-1/fulltext#.Ygflg2sVN8U.twitter
Thanks to Elsevier Inc for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.